GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » Inventories, Raw Materials & Components

Recordati SpA (Recordati SpA) Inventories, Raw Materials & Components : $0 Mil (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA Inventories, Raw Materials & Components?

Recordati SpA's inventories, raw materials & components for the quarter that ended in Dec. 2023 was $0 Mil.

Recordati SpA's annual raw materials increased from Dec. 2021 ($76 Mil) to Dec. 2022 ($98 Mil) but then declined from Dec. 2022 ($98 Mil) to Dec. 2023 ($0 Mil).


Recordati SpA Inventories, Raw Materials & Components Historical Data

The historical data trend for Recordati SpA's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Inventories, Raw Materials & Components Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.65 90.99 75.93 97.54 -

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Recordati SpA Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Recordati SpA (Recordati SpA) Business Description

Industry
Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020